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into the circulation, yet little is known about the active
regulation of lipid uptake by these lymphatic vessels, and
there lacks in vitro models to study the lacteal—enterocyte
interface. We describe an in vitro model of the human
intestinal microenvironment containing differentiated
Caco-2 cells and lymphatic endothelial cells (LECs). We
characterize the model for fatty acid, lipoprotein, albumin,
and dextran transport, and compare to qualitative uptake of
fatty acids into lacteals in vivo. We demonstrate relevant
morphological features of both cell types and strongly
polarized transport of fatty acid in the intestinal-to-lym-
phatic direction. We found much higher transport rates of
lipid than of dextran or albumin across the lymphatic
endothelial monolayer, suggesting most lipid transport is
active and intracellular. This was confirmed with confocal
imaging of Bodipy, a fluorescent fatty acid, along with
transmission electron microscopy. Since our model recapi-
tulates crucial aspects of the in vivo lymphatic–enterocyte
interface, it is useful for studying the biology of lipid
transport by lymphatics and as a tool for screening drugs
and nanoparticles that target intestinal lymphatics.
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transport of dietary lipid from the gut. In the small intestine,
enterocytes reesterify the majority of free fatty acids (FFAs)
absorbed from the lumen of the gut into triacylglycerols
which are then incorporated into chylomicrons (Tso and
Balint, 1986) and secreted basally to be picked up solely by
lacteals, which are blind-ended lymphatic vessels in the
center of each villus (Azzali, 1982; Schmid-Scho¨nbein,
1990). Since the lymphatic vessels are the first tissue that
chylomicrons encounter, as they are too large to be taken up
by the surrounding blood capillaries (Tso and Balint, 1986),
it is likely that lymphatic endothelium may actively regulate
the transport and processing of dietary lipid; however, little
is known about the biology governing lipid transport and
metabolism by lymphatics. Nearly all in vivo studies of the
synthesis of intestinal lipoproteins have relied on lymphatic
drainage for the collection of chyle to study enterocyte
assembly of lipids (Hayashi et al., 1990, 2002; Osada et al.,
1994), yet it is difficult with these techniques to identify the
specific contributions of lymphatics and differentiate them
from those of enterocytes.
Lymphatic transport in the intestine, like in other
locations throughout the body, is likely to be highly
sensitive to fluid forces in the interstitium. For example,
modulating tissue hydration of the interstitial matrix was
shown to have profound effects on chylomicron transport
presumably by altering lymph flow (Tso et al., 1985).
Lacteals themselves also seem to have the capacity to
physically adapt to a change in the load placed upon the
vessel as it has been observed that lacteals alter their
morphology in response to fasting and feeding (Habold
et al., 2007). It remains to be determined, however, exactly
how lymphatics actively regulate lipid uptake, or if responses
by lymphatics such as these are merely reactions to changes 2009 Wiley Periodicals, Inc.
in the interstitial fluid forces. One recent study suggested
that there may be some active regulation of lipid metabolism
by lymphatic endothelium, although direct mechanisms
remain elusive. It was found that mice with lymphatic
developmental abnormalities due to a heterozygous muta-
tion in Prox-1, which regulates lymphatic lineage com-
mitment, develop adult-onset obesity as a result of leaky
lymphatic vessels due to a loss of vessel integrity (Harvey
et al., 2005). In addition, there have been several other recent
editorials, short papers, and reviews that have alluded to or
commented on the possible connection that might exist
between lipid homeostasis and lymphatic function (Harvey,
2008; Rockson, 2004; Rosen, 2002; Ryan, 2006). The above-
mentioned correlations between lymphatic function and
lipid transport and metabolism remain largely phenomen-
ological, primarily due to the lack of an experimental in vitro
model that accurately recapitulates lipid transport from the
enterocyte to the lacteal.
While some in vivo models exist [e.g., TEM studies
(Azzali, 1982) or the lymph-fistula rat model (Hayashi et al.,
1990)], they are limited in their preparation difficulty as well
as ability to differentiate the lymphatic response to lipid
from the immune response due to the close correlation
between inflammation and lipid accumulation (Rutkowski
et al., 2006). An in vitro model is needed to study human
cells, for high throughput experiments, and to tease out
specific responses of lymphatics, as well as to precisely
examine biological regulation of lipid transport, yet no in
vitro model exists to the best of our knowledge. Here we
develop and characterize an in vitro model of the enterocyte-
lacteal interface for studies of lipid uptake and transport and
demonstrate its usefulness as a tool for quantifying the
functional transport of lipid by lymphatics. By incorporat-
ing Caco-2 cells that have undergone differentiation in
a transwell system, extracellular matrix, and lymphatic
endothelial cells (LECs), we have modified a well-established
model of chylomicron assembly to absorb and secrete lipid
in the form of chylomicrons and FFAs that can then be
transported across LECs. In order to establish the usefulness
of such a model for studying both lipid uptake and drug
delivery (Porter et al., 2007; Trevaskis et al., 2008), we
demonstrate its relevance to the in vivo environment and
report baseline measurements of FFA and lipid transport
through this in vitro model.Materials and Methods
Cell Lines
Caco-2 cells (LGC Promochem, Middlesex, England) were
expanded in high glucose DMEM (PAA, Pasching, Austria)
supplemented with 20% FBS, 1% antibiotic-antimicotic
mixture (both from Invitrogen, Carlsbad, CA). The media
was changed every 2 days and the cells were not allowed to
reach confluence before being passaged. The Caco-2 cells
used in experiments were between passages 20 and 30. LECswere obtained through an isolation from human neonatal
foreskins via immunomagnetic separation using the LEC
marker LYVE-1 as described previously (Podgrabinska et al.,
2002). The LECs were expanded in flasks that had been
previously coated for 1 h with a collagen solution containing
type I rat tail collagen (BD Biosciences, San Jose, CA) at a
concentration of 50 mg/mL and 0.1% acetic acid (Sigma, St.
Louis, MO). The cells were grown in EBM (Lonza, Basel,
Switzerland) supplemented with 20% FBS, 1% Glutamax,
1% penicillin-streptomycin (all from Invitrogen), 25 mg/mL
cyclic-AMP, and 1 mg/mL hydrocortisone acetate (both
from Sigma). LECs were split before reaching confluence
and were used in experiments between passages 7 and 10.Coculture and Experimental Setup
Caco-2 cells were seeded at a density near confluence
(1.5 105 cells/cm2) onto the bottom of a 0.4 mm pore size
transwell (Corning Life Sciences, Koolhovenlaan, The
Netherlands) that had been coated with collagen using
the same technique described above. The cells were given
an hour to attach to the membrane before inverting the
hanging transwells into a 12-well plate. The cells were treated
with the same medium described above, and the medium
was changed every 2 days until 21 days after the cells reached
confluence, allowing for differentiation into an enterocyte
phenotype (Pinto et al., 1983). Transepithelial electrical
resistance (TER) measurements were made to ensure that a
highly resistive cell layer had formed. The transwell insert
was then coated with the previously mentioned collagen
solution and seeded with LECs at a high density (105 cells/
cm2). The cells were cultured together with their respective
media bathing each side of the transwell for 3 days. The
media on both sides was then replaced with DMEM
containing 2% FBS for 12 h before experiments on the
culture model were performed. Unless specified otherwise,
all transport studies were carried out in DMEM with 2%
FBS, which was chosen to provide the cells with essential
nutrients yet minimize the effect of serum on the
experiments.Immunofluorescence
To whole-mount stain mouse lacteals, a 5 cm segment of
mouse small intestine was isolated from the proximal region
and fixed overnight in 4% PFA at 48C. After blocking, the
tissues were treated with the respective primary antibodies,
LYVE-1 at a dilution of 1:500 (Millipore, Billerica, MA) and
CD31 at a dilution of 1:200 (BD Biosciences) overnight at
48C in PBS containing 2% bovine serum albumin (PAA).
The tissues were rinsed and then stained for 1 h at room
temperature with the appropriate secondary antibody
(Invitrogen) at a dilution of 1:200.
Transwell membranes were fixed for 15 min with 4% PFA
at room temperature immediately after the collection of
media samples for the plate reader, which occurs 6 h after theDixon et al.: A Tissue-Engineered Lacteal 1225
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addition of the tracer of interest. All in vitro staining
presented here is representative of the cells at this 6 h time
point. Antibody staining was performed using the same
protocol as described above with VE-Cadherin (BD
Biosciences) at a dilution of 1:50. Alexa-labeled phalloidin
(Invitrogen) was added (diluted 1:50) with the secondary
solution.Scanning Electron Microscopy
Caco-2 cells were fixed in 2% glutaraldehyde (Sigma) for 2 h
at various time points during their differentiation. They
were then prepared for SEM by washing in Sorensen buffer
solution (Labo-Moderne, Paris, France) and treating with
1% osmium tetroxide (Sigma) for 1 h. They were then
dehydrated in a sequence from 25% to 100% ethanol, dried
by CO2 critical point, coated with 20 nm gold, and imaged
with a JSM 6300F electron microscope equipped with the
Mamiya 6 7 UHR (TMX120 ISO100) camera (Joel Ltd,
Tokyo, Japan).Transmission Electron Microscopy Preparation
Cells were fixed in freshly prepared fixative (2.5%
glutaraldehyde, 2% paraformaldehyde) at 48C for 4 h and
then rinsed and stored overnight at 48C in PBS. The
following morning samples were washed 3 in cacodylate
buffer (0.1 M, pH7.4) at 48C. They were then postfixed in
1% osmium tetroxide and 1.5% potassium ferrocyanide in
cacolydate buffer for 40 min. The solution was then changed
out with 1% osmium tetroxide in cacolydate buffer and
incubated for an additional 40 min. Cells were washed twice
with distilled water and stained with 1% uranyl acetate for
40 min. The cells were washed again in distilled water and
then dehydrated with washes of increasing ethanol concen-
tration (1 50%, 1 70%, 2 96%, 2 100%). Cells were
embedded in 1:1 solution of Durcapan and 100% ethanol for
30 min while rotating the sample. The solution was replaced
with fresh Durcapan and samples were rotated for an
additional 1 h. This step was repeated twice. Cells immersed
in Durcapan were then placed in the oven at 658C overnight
to allow the resin to harden. The next day samples were
sliced into 50 nm sections using a diamond knife and then
mounted on grids for viewing later.Permeability Measurements
The intestinal side of the transwell was treated with either
70 kDa Texas Red—dextran, 3 kDa Cascade Blue—dextran,
FITC—albumin, or Bodipy FL C16, a fluorescently labeled
16 carbon chain fatty acid, (all from Invitrogen) or some
combination thereof (Fig. 1A). In some cases, 1.6 mM oleic
acid (OA) and 1.0 mM taurocholic acid (TC, both from
Sigma) (OA/TC), which are known to promote chylomicron1226 Biotechnology and Bioengineering, Vol. 103, No. 6, August 15, 2009formation (Luchoomun and Hussain, 1999), were added to
the intestinal side of the transwell. At 6 h, two 150 mL
samples were collected from the lymphatic side of the
transwells and their fluorescence was measured in a Safire2
plate reader (Tecan, Ma¨nnedorf, Switzerland) and com-
pared to a standard curve to estimate Peff (mm/sec) using a
previously established method (reviewed in Mehta and
Malik, 2006; Michel and Curry, 1999). Briefly, effective
permeability to a tracer was calculated as a function of
the solute flux Js (mg/sec), the concentration gradient DC
(mg/mL), and the surface area of the monolayer S (cm2):
Peff ¼ JS
DCS
After 6 h, the solute concentration on each side was
determined by correlating the fluorescence reading with a
standard curve, and Js was determined by multiplying the
concentration in the lower well by the medium volume
(0.5 mL) and dividing by the time course of the experiment
(6 h). Pilot experiments were performed in which samples
were taken at multiple time points to ensure that the flux was
linear over the duration of the experiment; we chose one 6-h
time-point rather than multiple time-points because of
potential error due to convection and mixing from multiple
sampling.
To measure transport across LECs alone, we treated Caco-2
cells with OA/TC and Bodipy as above, and collected the
secretions after 12 h. The secretions from multiple wells were
pooled together and diluted in DMEM containing 2% FBS
and were placed on the LECs for 1 h. This shorter time point
for LECs alone was chosen because we found that the
transport of Bodipy-containing secretions across the LEC
monolayer was much faster than Bodipy transport across the
two-cell model.Gel Filtration Chromatography
To separate size fractions containing secreted proteins from
the two-cell model, we used gel filtration chromatography
(GFC) to size-separate lipoproteins from serum (Orth et al.,
1998). Specifically, we layered two Sepherose gels in a 1 cm
wide column: the lower 55% of the column height was filled
with Sepherose CL-6B and the upper 45% was filled with
Sepherose CL-2B (both from Sigma) for a total height of
either 16 or 19 cm. A sample volume of 0.5 mL was loaded
on the top of the column and filtered at a flow rate of
approximately 750 mL/min (filtration buffer: 145 mM NaCl,
0.21 mM Na2EDTA, and 25 mM Tris, pH 7.5), which was
provided by a constant pressure head. Forty-eight fractions
were collected in 0.5 mL volumes and saved for analysis.
Two hundred microliters samples were extracted from each
sample and the relevant fluorescence was read on a Safire2
plate reader. Samples containing Texas red-labeled albumin
(10 mg/mL, Invitrogen) or 200 nm beads (10 mg/mL,
Invitrogen) were run through the column as size standards.
Figure 1. The in vitro model recapitulates the morphology of the lymphatic—enterocyte interface. A: Schematic and CAD drawing of the transwell system. B: TEM image of
an orthogonal slice of the transwell showing the relative thickness of each layer: Caco2 cells (20 mm), transwell membrane (12 mm), LECs ( 5 mm). C: Caco-2 cells develop
columnar morphology with nuclei located near the basal surface of the cell; f-actin is stained with phalloidin (red), nuclei with DAPI (blue), and fatty acid with Bodipy (green).
D: LECs, plated on the top of the insert, show typical morphology and cell–cell junctions (VE-Cadherin, red), and contain fatty acid-containing vesicles (Bodipy, green). E: The Caco-2
cell layer, plated on the bottom of the transwell, contains tightly packed cells (phalloidin, red; nuclei, blue) containing numerous Bodipy-containing vesicles (green). F and G:
Scanning electron micrographs of the Caco2 cell surface after 2 days (F) or 3 weeks (G) of culture showing the formation of microvilli (black arrow) over time characteristic of
enterocyte differentiation. H: 3-D reconstruction of confocal slices of a mouse intestinal villus with a lymphatic vessel in the center; nuclei are stained with DAPI (light blue), blood
vessels with CD-31 (red), and lymphatic endothelium with LYVE-1 (green). I: Cross-section of a lacteal exhibits the lacteal located in the center of the villus, perpendicular to the
imaging plane; the distance between the apical side of the enterocyte and the basal side of the lymphatic is approximately 40 mm. J: Side view of the 2-cell model system showing a
similar enterocyte—lymphatic distance as that seen in vivo.For samples that had been treated with OA/TC (but not
Bodipy), the secretions were incubated with C6-NBD-
ceramide (1 mg/mL, Invitrogen) for 30 min to allow the
probe to be incorporated into the lipoproteins before being
run through the column.Quantification of Total Lipid
In the GFC size-separated fractions that labeled positively
with NBD, we used an extraction method to measure total
lipid (Amenta, 1970). Three hundred microliters of ourDixon et al.: A Tissue-Engineered Lacteal 1227
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sample was added to 1 mL of a 45% chloroform, 55%
methanol solution and mixed vigorously for 5 min. The
sample was allowed to stand for 1 h, mixing again every
20 min. 2.7 mL of 5 mg/mL CaCl2 dissolved in water
was added and shaken vigorously for 5 min. The sample
was spun at 1,000g to separate the phases and 200 mL was
extracted from the bottom phase containing the lipid and
chloroform. This sample was evaporated at 1108C and
resuspended into 1 mL of a dichromate solution (200 mg
of K2Cr2O7 dissolved into 2 mL of water and the diluted with
40 mL of H2SO4). Forty microliters of this sample was
diluted in 160 mL water and its absorbance at 430 nm was
measured with a plate reader. A standard curve was made by
running samples of LDL at a known concentration (Lee
BioSolutions, St. Louis, MO) of various dilutions through
the same procedure. This curve was used to calculate the
total lipid in each fraction based on the absorbance reading
at 430 nm.Animal Experiments
All protocols were approved by the Veterinary Authorities of
the Canton Vaud according to Swiss law (protocol no.
1952). Mice were administered 300 mL of a lipid cocktail
containing water (100 mL), olive oil (100 mL), cream (35%
milk fat) (100 mL), 70 kDa dextran (30 mg), and Bodipy
FL C16 (30 mg) via gavage. After 1 h the animal was
anesthetized with a subcutaneous injection of ketamine
(3.75 mg/100 g body weight) and xylazine (0.75 mg/100 g
body weight). Supplemental doses of the anesthetic were
given as needed. An abdominal incision was made and a
loop of the small intestine was exteriorized through the
incision and gently positioned over a semicircular viewing
pedestal on a Plexiglas preparation board designed to supply
the vessel with crucial nutrients and maintain temperature.
A lymphatic vessel was identified by its morphology and/or
the presence of Bodipy and centered over an optical window
in the preparation board. The exteriorized tissue was
perfused with an albumin physiological salt solution (in
mM): 145.00 NaCl, 4.7 KCl, 2.0 CaCl2, 1.17 MgSO4, 1.2
NaH2PO4, 5.0 dextrose, 2.0 sodium pyruvate, 0.02 EDTA,
3.0 MOPS, and 10g/L bovine serum albumin (all from
Sigma) that was pre-warmed to 388C, and the pH adjusted
to 7.4. The temperature of the exteriorized tissue and the
animal’s core was maintained at 36–388C (Dixon et al.,
2006). Temperature was monitored with a thermocouple
probe throughout the experiment. The mesenteric lympha-
tics were imaged under a Leica MZ16 FA fluorescence-
equipped stereomicroscope.Statistics
All statistics were performed using SPSS (Chicago, IL).
Statistical significance between groups was established using
one-way ANOVA followed by a Tukey post-hoc test to
correct for multiple comparisons.1228 Biotechnology and Bioengineering, Vol. 103, No. 6, August 15, 2009Results and Discussion
Replicating In Vivo Morphology
The first goal was to recapitulate key morphological and
functional features of the enterocyte-lacteal interface in
vitro, therefore we optimized and characterized features
relevant to lipid and FFA transport across LECs. Caco-2 cells
were used since they can be differentiated into cells with
similar morphology and function to enterocytes, the
epithelial cell responsible for lipid absorption and lipopro-
tein assembly in the intestine, and are well-characterized for
lipoprotein synthesis (Levy et al., 1995; Luchoomun and
Hussain, 1999; Pinto et al., 1983). However, there are a few
noteworthy differences between enterocytes and Caco-2
cells. Caco-2 cells synthesize both ApoB-100 (present in
the liver) and ApoB-48 (intestinal form); however, when
cultured on transwells and allowed to differentiate, the
ApoB-48/ApoB-100 ratio is maximized. Caco-2 cells also
express much lower levels of intestinal fatty acid binding
protein (I-FABP) than enterocytes, although I-FABP is not
necessary for Caco-2 cells to absorb and metabolize long
chain fatty acids (Darimont et al., 1998). In addition,
synthesis of fat via the monoacylglycerol pathway in Caco-2
cells is much lower than that observed in vivo (Levy et al.,
1995; Trotter and Storch, 1993). However, since our primary
interest is to utilize the ability of Caco-2 cells to assemble
and secrete chylomicrons from a source of fatty acids, it is a
useful model cell line for this study. Human dermal LECs
were used because of a lack of a human lacteal cell line;
however, there has not yet been any evaluation of how
dermal versus intestinal lymphatic capillaries differ.
By staggering the timing of cell seeding, Caco-2 cells are
allowed to first differentiate and develop their enterocyte
phenotype, before LECs are added to the transwell. When
cultured together in the transwell system (Fig. 1A), LECs
and Caco-2 cells formed separate confluent monolayers on
opposite sides of the membrane with the membrane itself
separating the cells by approximately 12 mm (Fig. 1 B). The
Caco-2 cells developed a typical columnar morphology with
the nucleus located near the basal surface of the cell
(Fig. 1C), and TER measurements verified a tight junctional
integrity (data not shown). Both cell types appeared to form
typical morphologies (Fig. 1D and E). VE-cadherin staining
on LECs revealed a discontinuous expression pattern
(Fig. 1D) characteristic of initial lymphatics (Baluk et al.,
2007), and no apparent difference was seen in response to
chylomicron secretion by Caco-2 cells. This is consistent
with previous in vivo SEM studies on lipid uptake into
lacteals in which the junctions between adjacent lymphatic
endothelial cells of the rat lacteal remain closed during both
fasting and feeding conditions (Azzali, 1982; Dobbins and
Rollins, 1970).
The model setup allows for fatty acid and lipid transport
from the apical side of the Caco-2 cells to the apical side of
the LEC monolayer to be quantified in a plate reader and for
lipid trafficking through the cells to be imaged with confocal
microscopy. While the green fluorescent Bodipy can be seen
in vesicle-like compartments in both cell types (Fig. 1D and
E), Bodipy-containing vesicles were more predominant in
the intestinal cells, as these cells provide the rate-limiting
step in fatty acid uptake into lymphatics (Tso and Balint,
1986). Microvilli on the Caco-2 cells, which further
demonstrated enterocyte differentiation as characteristic
of the brush border organization seen in vivo (Pinto et al.,
1983), while not present after 2 days of culture (Fig. 1F) were
seen under scanning electron microscopy (SEM) after being
kept in culture for 3 weeks (Fig. 1G).
Since the main focus of this model is to study transport, it
is essential that the transport distance between the two
physiologic compartments is similar to what occurs in vivo.
In vivo, enterocytes and blood vessels surround the lacteal in
the center of each intestinal villus (Fig. 1H), and the distance
between the lymphatic and the apical surface of the
enterocyte is approximately 40 mm (Fig. 1I). In our in
vitro model, the distance between the apical side of the
enterocytes and the apical side of the LECs was approxi-
mately 40 mm (Fig. 1J), of which the insert contributed
12 mm.Replicating In Vivo Function
To assess functionality, we adapted for the mouse a
preparation used in previous studies of rat mesenteric
lymphatic function (Dixon et al., 2005, 2006, 2007) and
imaged Bodipy uptake into lymphatic vessels in the
anesthetized mouse. When the same volume and concen-
tration of Texas Red-conjugated dextran (70 kDa) was co-
delivered with Bodipy, Bodipy was seen to be transported
through the intestine and taken up by lymphatics (Fig. 2A),
while dextran was not visible in any tissues outside of
the intestine (Fig. 2B). Multiple images of the intestine
were taken at various exposure times to ensure that the
differences seen were not due to differences in the quantum
yield of the dye (data not shown). The differences between
the uptake of dextran and Bodipy into lymphatics can be
clearly seen in higher magnifications of individual vessels
20 mm in diameter (Fig. 2C–E).
Likewise, in our in vitro model, we found that only
Bodipy was transported across to the lymphatics, while
Caco-2 cells prevented the transport of dextran and albumin
(Fig. 2F). We also quantified transport for a range of dextran
sizes (10, 70, and 2,000 kDa) that were fluorescently labeled.
While all three were transported through LECs alone to
varying degrees, no transport was detected through the two-
cell layer or through Caco-2 cells (data not shown) within
the timeframe of the experiment. When comparing the
transport of dextran and albumin through each cell type
individually and through the two-cell model, it was clear
that the Caco-2 cells provided the main barrier to transport
of these two molecules. However, the opposite was true for
Bodipy as Caco-2 cells modify Bodipy to be transported
more effectively through LECs than when it is added to LECsalone under the same 2% serum conditions (Fig. 2F). This
was further confirmed by adding secretions from Caco-2
cells, which had been previously treated with Bodipy, onto
LECs. Bodipy in this form, was transported over 50 times
more rapidly than when it was added directly to LECs
and was also transported much more effectively than
fluorescently labeled albumin (Fig. 2G).
For certain experiments it would be advantageous to grow
the two cell types separately and characterize the transport of
Bodipy through each compartment separately (e.g., to
chemically block specific mechanisms of transport in LECs
without affecting the transport through the enterocyte layer
or vice versa). By collecting secretions from Caco-2 cells that
have been treated with Bodipy and OA/TC, and then placing
this media directly onto LECs, we could calculate the
permeability of LECs alone to these secretions. When
the two different cell types were cultured separately and
transport of Bodipy was measured in each stage individually,
the sum of the resistance (1/Peff) to Bodipy transport of
each cell compartment should be equal to the resistance
of Bodipy transport through the two cell model, thus
the total permeability of two compartments in series with
known permeability can be calculated with the following
equation:
1
Peff
¼ 1
P1
þ 1
P2
When the total permeability of Caco-2 cells and LECs
placed in series was calculated from the experimental
permeability measured for each cell type individually, the
result agreed well with the effective permeability measured
experimentally in the two-cell model (Fig. 2H).
Previous work characterized the uptake of Bodipy Fl C16
by Caco-2 cells (Thumser and Storch, 2007) and showed
that the probe targeted the endoplasmic reticulum/golgi
apparatus and that no localization of the probe was found in
the lysosome after 15 min, suggesting that the probe would
be targeted for subsequent use as an energy substrate for
esterification into phospholipids and triacylglycerols that
would then be incorporated into lipoproteins. In order to
determine what size range of proteins the Bodipy was being
incorporated into, we performed gel filtration chromato-
graphy (GFC). Since FFAs are known to bind albumin, we
compared serum-free conditions with 2% serum-containing
medium when examining Bodipy transport across the two-
cell model. In serum-free conditions, the Bodipy elutes with
a much later fraction than albumin, suggesting that Bodipy
was associated with smaller molecules (Fig. 3A). However, in
2% serum, most of the Bodipy elutes in the same fraction as
albumin, while a small peak is seen in an earlier fraction
(arrow in Fig. 3A), suggesting that at least some of the
Bodipy is incorporated into a larger lipoprotein such as
a chylomicron. It is important to note that the Bodipy-
containing Caco-2 secretions, even if mostly bound
albumin, were transported across the LEC monolayer
ten times more rapidly than was albumin (Fig. 2F–G),Dixon et al.: A Tissue-Engineered Lacteal 1229
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Figure 2. The in vitro model recapitulates key features of in vivo lipid absorption function. A: Bodipy (green) is specifically taken up from the intestine (black arrow) into
lymphatic vessels (arrowhead) and not blood vessels (white arrow) after oral delivery. B: 70 kDa Texas Red—dextran, while visible in the intestine (black arrow) after oral delivery,
is not visible in the lymphatics or the blood vessels. C: Enlarged region from (A) as indicated, where Bodipy can clearly be seen inside the lymphatic vessel. D: Enlarged region from
(B), taken at the same exposure time as (C), shows that dextran is not visible in the Bodipy-containing lymphatic. E: Enlarged region from (B) taken at six times the exposure time
shows that the red fluorescence in the lymphatic vessel is indistinguishable from background fluorescence. F: Similar to the in vivo case, the two-cell model transports fatty acid
much more rapidly than other proteins or large dextrans (bars not sharing the same letters are statistically significantly different, P< 0.05). In all cases, the tracer was added to the
underside (Caco-2 apical side) of the insert and collected from the top (LEC apical side). G: Bodipy is transported much more effectively across a monolayer of LECs after it has been
absorbed and secreted by Caco-2 cells (Caco2-Bodipy) first, which was achieved by adding Bodipy-containing Caco-2 secretions onto LECs, compared to when Bodipy is added
directly to LECs (P< 0.01). H: The Caco-2 cell permeability to Bodipy and the LEC permeability to Caco-2 secreted Bodipy can be used to predict the permeability of the two-cell
model to Bodipy (Pred 2-cell), which agrees well with experimental results (2-cell).indicating that albumin-associated bodipy is transported
differently across LECs than albumin.
To further demonstrate chylomicron secretion from the
two-cell model, secretions from Caco-2 cells treated with
OA/TC were labeled with C6-NBD-ceramide, which is
known to bind to lipoproteins (Hosken et al., 2005), filtered
using GFC, and then the fluorescence of each fraction was
measured with a plate reader. Lipoproteins were eluted
similarly as 200 nm beads (Fig. 3B), indicating a size range
consistent with chylomicrons. The total lipid in these
fractions (8–13) was determined by extraction followed by
incubation with a dichromate solution and absorbance
reading as described in Materials and Methods Section.1230 Biotechnology and Bioengineering, Vol. 103, No. 6, August 15, 2009Much more lipid was found in OA/TC-treated Caco-2 cell
secretions than without the OA/TC (Fig. 3C), which
promotes chylomicron formation (Luchoomun and Hus-
sain, 1999). Furthermore, when Pluronic L-81, a hydro-
phobic polymer known to inhibit the formation of large
chylomicrons (Luchoomun and Hussain, 1999; Tso et al.,
1980), was added to the solution at 1 mg/mL, no lipid was
detected in fractions 8–10, while lipid was present in some of
the later fractions (11–13); this indicated that the size range
of the lipid-containing species was shifted to a smaller range
upon addition of Pluronic L-81. It should be noted that the
column used in Figure 3B and C was larger than that used for
the data in Figure 3A, and thus albumin elution occurs at
Figure 3. Bodipy is secreted by Caco-2 cells in both lipid-associated and
albumin-associated species. A: Bodipy secreted by Caco-2 cells is contained in a
lower size fraction than albumin when the experiment is carried out in serum-free
conditions, but in 2% serum, the Bodipy elutes in higher size fractions, with the
predominant fraction being that which contains albumin, suggesting albumin
binding in the two-cell model. A smaller percentage of the Bodipy is associated
with larger size fractions (arrow), indicating lipoprotein incorporation. B: OA/TC
treated Caco-2 secretions contain lipoproteins labeled with NBD-ceramide (OA/TC
(NBD)) that elute with 200 nm nanoparticles. C: OA/TC treated Caco-2 cells secrete
substantially more lipid as compared to untreated cells in the fractions highlighted
in (B), suggesting the formation of lipid-rich lipoproteins. The amount of lipid in the
larger fractions is drastically reduced when Pluronic L81, a hydrophobic polymer
known to interfere with the formation of large chylomicrons, is added to the OA/TC
treated cells.different fractions. Also, the second peak in the NBD sample
corresponds to the free NBD remaining in the solution,
as it corresponds to samples containing only NBD (data not
shown).
Together, these findings suggest that most of the Bodipy
transported across the two-cell model is associated with
albumin, but a significant fraction is associated with larger
lipid particles. Furthermore, it shows that lipid transport can
be measured and manipulated across the model.Lymphatic Transport of Bodipy Occurs Through Both
Transcellular and Paracellular Pathways
Using confocal microscopy on the LEC monolayer, we
observed fluorescent Bodipy both in cytoplasmic vesicles
within the cell and associated with overlapping cell-cell
junctions (Fig. 4A–C), as indicated by immunostaining for
VE-cadherin (Fig. 4C), which controls permeability in both
blood and lymphatic endothelium (Baluk et al., 2007;
Dejana, 2004; Ng et al., 2004). This suggests that both
transcellular and paracellular pathways may be used for
Bodipy transport across LECs, although the vast majority of
Bodipy was seen clearly within the cell boundaries. In these
cases, Bodipy was often seen in vesicles that lined up in a
chain-like fashion, and the size of these vesicles suggests the
formation of vesiculo-vacuolar organelles or transendothe-
lial channels (Fig. 4B) (Feng et al., 2002). It is uncertain
whether the Bodipy observed within these cells was attached
to albumin, incorporated into a lipoprotein, or bound to a
fatty acid binding protein. Others have shown, as we have in
Figure 2, that when delivered in vivo, Bodipy is taken up
directly into lymphatics (Harvey et al., 2005). In addition to
this, free fatty acids have been shown to be present in
intestinal lymph after feeding (Beckett et al., 1981;
Blomstrand and Dahlback, 1960; Papp and Makara,
1965), yet the importance or regulation of free fatty acid
transport by lymphatics is unclear. Thus, Bodipy C16 is a
potentially interesting probe to investigate more closely the
mechanisms of free fatty acid transport by lymphatics and
the role of albumin in this process.Transport Is Polarized in the Enterocyte to
Lymphatic Direction
In our in vitro model, we found that Bodipy transport was
polarized in a physiologically relevant direction (Fig. 4D).
Evidence of this polarization, which is characteristic of
enterocyte-like differentiation of Caco-2 cells, was also seen
with confocal imaging, where numerous Bodipy-containing
vesicles were seen in the Caco-2 cells when transport was in
the intestinal-to-lymphatic direction (Fig. 4E) but none
were observed when concentration gradients were reversed
(Fig. 4F). This is expected because the luminal side of
enterocytes have numerous microvilli located at what is
known as the brush border, which increases the surface area
and enhances lipid absorption (Tso and Balint, 1986). ThisDixon et al.: A Tissue-Engineered Lacteal 1231
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Figure 4. Bodipy is transported via both paracellular and transcellular pathways through LECs in vitro. All images show LECs on the underside of the culture insert membrane
that were in coculture with Caco-2 cells treated with Bodipy and OA/TC. A: Maximum projection confocal image of LECs stained with VE-Cadherin (red) show Bodipy (green) being
transported both transcellularly (arrowhead) and paracellularly (arrow). B: Cross-section of a single LEC stained with VE-Cadherin, showing Bodipy transcytosing through the cell
via vesicles in a chain-like fashion. C: Enlarged view of the insert marked in (A) demonstrates Bodipy traversing through the cell and overlapping with VE-cadherin as shown from
two different perspectives: perpendicular to the imaging plane (left) and parallel to the imaging plane (right). D: Effective permeability (Peff) of the two-cell model to Bodipy was
much higher when lipid is added to the Caco-2 side of the transwell as compared to the LEC side, demonstrating polarization of transport. E: Vesicles containing Bodipy (green) were
observed inside the Caco-2 layer when Bodipy was added to the intestinal side of the co-culture model. F: Vesicles were absent from the Caco-2 cell layer when the same
concentration of the probe was added to the LEC side of the co-culture model, demonstrating polarization in transport.polarization of lipid transport is critical for model validation
regarding its usefulness in lipid transport studies.Lymphatic Transcytosis of Lipoproteins
Electron microscopy studies have demonstrated uptake of
chylomicrons and other large particles into lymphatics in
vivo via both transcellular and paracellular pathways (Azzali,1232 Biotechnology and Bioengineering, Vol. 103, No. 6, August 15, 20091982; Dobbins and Rollins, 1970; Feng et al., 2002), and here
we demonstrate lipid transcytosis across LECs in vitro
(Fig. 5). Using TEM of the two-cell model, we observed
numerous lipid vesicles within LECs in the two-cell model
that were treated with OA/TC to promote chylomicron
formation by Caco-2 cells (Fig. 5A–C). Vesicles were often
seen fusing with the cell membrane on both the apical side as
they took up lipid and the basal side as they released it
(Fig. 5A and B). It is interesting to note that these vesicles are
Figure 5. Lipoprotein transcytosis observed within in vitro lymphatic endothelial
cells (LECs) in the two-cell model using TEM. A: Lipid-containing vesicles (arrow) are
seen transcytosing across the LEC even in the proximity of an overlapping junction
(arrowhead). B: Lipid particle being released on the apical surface of a LEC
(arrow) along with a lipid particle entering on the basal surface of the LEC
(arrowhead). C: Three LECs with overlapping cell junctions (arrowheads) containing
lipid vesicles transcytosing through the cells. D: In the untreated controls (no OA/TC to
promote chylomicron formation by Caco-2 cells), lipid-containing vesicles were rarely
seen, while the overlapping junctions (arrow) were similar to those in lipid-transport-
ing cells. E: Overlapping junctions (arrow) that are completely closed occur quite
regularly, even in the presence of the lipid load. F: Microvilli and numerous intracellular
vesicles seen on a Caco2 cell in the two-cell model. G: Lipid could be seen transporting
within a pore in the insert membrane and on the basal side of the LEC (arrows)
along with lipid-containing vesicles inside the cell (arrowhead). H: Abnormally large
vesicles (arrow) containing multiple lipid particles were occasionally seen within LECs
(nucleus, arrowhead).present even in areas of overlapping lymphatic cell edges
(Fig. 5A and C, arrowheads).
In contrast, very few lipid-containing vesicles were found
in LECs from samples that were not treated with OA/TC
(Fig. 5D), which further suggested that the vesicles in OA/
TC treated samples contained chylomicrons. Even in the
case of OA/TC treated samples, the junctions remain closed
with very little gaps as was seen by a high-magnification
image of one of these overlapping junctions (Fig. 5E). Brush
border-like microvilli on the apical surface of the Caco-2
cells was maintained even after co-culture with LECs
(Fig. 5F). Occasionally we observed pores of the insert
membrane, where lipid particles were seen within these
pores and on the basal side of a LEC (Fig. 5G). Sometimes
quite large vesicles were seen transporting multiple
chylomicrons or lipoproteins within the cell (Fig. 5H).
There remains uncertainty in the literature as to whether
transcellular pathways play major roles in the transport of
various particles by lymphatics under normal physiologic
conditions. Because of anchoring filaments and a unique
valve structure of loosely overlapping cell-cell junctions
(Baluk et al., 2007; Leak, 1970, 1971; Trzewik et al., 2001), it
is often assumed that lymphatic uptake of fluid and solutes is
primarily via paracellular routes; however, lymphatics are
known to contain numerous transport vesicles (Azzali, 1999;
Feng et al., 2002), and TEM images have shown vesicular
transport like that shown in Figure 5. Still, the relative
importance of each pathway for fluid, solutes, or chylo-
microns and other lipoproteins have not been determined.
While further studies are needed to explore this, our
model is useful for determining the effects of inhibiting
or enhancing transendothelial lipoprotein transport in
lymphatics immediately upon secretion by enterocytes.Conclusions
Tissue engineering has recently made important contribu-
tions to elucidating biological mechanisms in a variety of
systems (Griffith and Swartz, 2006), including the lympha-
tics (Griffith and Swartz, 2006; Helm et al., 2005, 2007),
although the latter has been to date limited to capillary
morphogenesis. Our tissue engineered model of the lacteal is
not only be beneficial for elucidating the biology of lipid
transport by lymphatics, it can serve as a tool for evaluating
the efficacy of drug formulations and delivery systems that
target lymphatics for oral drug delivery, which is desirable
since it would avoid first-pass clearance in the liver (Porter
and Charman, 1997; Porter et al., 2007; Rensen et al., 2001).
Our in vitro model of the lacteal exhibits the most
important characteristics relevant to lipid transport of the
enterocyte-lymphatic interface in vivo. With this model we
can measure the rate of fatty acid and lipid transport from
the intestinal lumen to the lumen of the lacteal and can
quantify how varying lipid content, lymphatic permeability,
or known routes of transcellular transport in endothelial
cells alter overall lipid transport. We can also examine theDixon et al.: A Tissue-Engineered Lacteal 1233
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contributions of each cell type individually to the transport
of a species as a whole and quantify the extent that the
transport is polarized in the physiologically relevant
direction. Using fluorescence imaging we can observe
how both paracellular and transcellular transport is utilized
by LECs for fatty acid transport, and with TEM we can
visualize transcytosis of chylomicrons across LECs, giving us
a novel tool to study the regulation of lipid transport and
metabolism by LECs. Not only is such a model beneficial for
studying some of our basic questions about lymphatic
function in lipid trafficking, but it will also be an important
tool for evaluating the efficacy of novel nanoparticles for oral
drug delivery.
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